Seguir
HW Reesink
HW Reesink
Afiliación desconocida
Dirección de correo verificada de amc.nl
Título
Citado por
Citado por
Año
Treatment of HCV infection by targeting microRNA
HLA Janssen, HW Reesink, EJ Lawitz, S Zeuzem, M Rodriguez-Torres, ...
New England Journal of Medicine 368 (18), 1685-1694, 2013
25602013
Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors
MMJ Nielen, D van Schaardenburg, HW Reesink, RJ Van de Stadt, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2004
24622004
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
21182017
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
15592018
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection
JG McHutchison, GT Everson, SC Gordon, IM Jacobson, M Sulkowski, ...
New England Journal of Medicine 360 (18), 1827-1838, 2009
14252009
A proposed system for the nomenclature of hepatitis C viral genotypes
P Simmonds, A Alberti, HJ Alter, F Bonino, DW Bradley, C Brechot, ...
Hepatology 19 (5), 1321-1324, 1994
13431994
Response-guided telaprevir combination treatment for hepatitis C virus infection
KE Sherman, SL Flamm, NH Afdhal, DR Nelson, MS Sulkowski, ...
New England Journal of Medicine 365 (11), 1014-1024, 2011
10472011
Sofosbuvir and ribavirin in HCV genotypes 2 and 3
S Zeuzem, GM Dusheiko, R Salupere, A Mangia, R Flisiak, RH Hyland, ...
New England Journal of Medicine 370 (21), 1993-2001, 2014
10272014
Telaprevir for previously treated chronic HCV infection
JG McHutchison, MP Manns, AJ Muir, NA Terrault, IM Jacobson, ...
New England Journal of Medicine 362 (14), 1292-1303, 2010
9492010
Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B …
VCW Wong, HW Reesink, HMH Ip, PN Lelie, EE Reerink-Brongers, ...
The Lancet 323 (8383), 921-926, 1984
816*1984
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir
C Sarrazin, TL Kieffer, D Bartels, B Hanzelka, U Müh, M Welker, ...
Gastroenterology 132 (5), 1767-1777, 2007
7722007
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
730*2014
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay
CL Van der Poel, HW Reesink, JJP van Boven, HTM Cuypers, I Winkel, ...
The Lancet 337 (8737), 317-319, 1991
6611991
ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype …
P Andreone, MG Colombo, JV Enejosa, I Koksal, P Ferenci, A Maieron, ...
Gastroenterology 147 (2), 359-365. e1, 2014
5392014
Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study
HW Reesink, S Zeuzem, CJ Weegink, N Forestier, A Van Vliet, ...
Gastroenterology 131 (4), 997-1002, 2006
5262006
Reliability of polymerase chain reaction for detection of hepatitis C virus
HL Zaaijer, HTM Cuypers, HW Reesink, IN Winkel, PN Lelie, G Gerken
The Lancet 341 (8847), 722-724, 1993
4891993
Telaprevir and pegylated interferon–alpha‐2a inhibit wild‐type and resistant genotype 1 hepatitis C virus replication in patients
TL Kieffer, C Sarrazin, JS Miller, MW Welker, N Forestier, HW Reesink, ...
Hepatology 46 (3), 631-639, 2007
4712007
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study
G Dusheiko, J Main, H Thomas, O Reichard, C Lee, A Dhillon, S Rassam, ...
Journal of hepatology 25 (5), 591-598, 1996
4501996
Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands
CL Van der Poel, PN Lelie, QL Choo, HW Reesink, AL Vaar-Kuypers, ...
The Lancet 334 (8658), 297-298, 1989
3941989
Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis
VP Van Halm, MMJ Nielen, MT Nurmohamed, D Van Schaardenburg, ...
Annals of the rheumatic diseases 66 (2), 184-188, 2007
3742007
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20